Insider · CIK 0001664281

PARMAR KUSH

Reports to the SEC for 18 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001664281

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-10	TRDAEntrada Therapeutics, Inc.S Sale	Director	SSale	−92.4K sh	$7.00	−$647K	2,691,337
2026-08-07	TRDAEntrada Therapeutics, Inc.S Sale	Director	SSale	−52.3K sh	$6.85	−$358K	2,783,781
2026-08-06	TRDAEntrada Therapeutics, Inc.S Sale	Director	SSale	−10.5K sh	$7.00	−$73.5K	2,836,098
2026-07-31	TRDAEntrada Therapeutics, Inc.S Sale	Director	SSale	−1,718 sh	$6.85	−$11.8K	2,846,592
2026-07-30	TRDAEntrada Therapeutics, Inc.S Sale	Director	SSale	−115K sh	$6.93	−$795K	2,848,310
2026-06-10	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19K sh	—	—	19,000
2025-11-14	TRDAEntrada Therapeutics, Inc.S Sale	Director	SSale	−200K sh	$8.80	−$1.76M	2,963,066
2025-07-09	TRDAEntrada Therapeutics, Inc.S Sale	Director	SSale	−6,935 sh	$7.50	−$52K	1,093,313
2025-07-09	TRDAEntrada Therapeutics, Inc.S Sale	Director	SSale	−20.1K sh	$7.50	−$151K	3,163,066
2025-07-01	TRDAEntrada Therapeutics, Inc.S Sale	Director	SSale	−6,422 sh	$7.12	−$45.7K	1,100,248
2025-07-01	TRDAEntrada Therapeutics, Inc.S Sale	Director	SSale	−18.6K sh	$7.12	−$132K	3,183,131
2025-06-30	TRDAEntrada Therapeutics, Inc.S Sale	Director	SSale	−6,422 sh	$6.81	−$43.8K	1,106,670
2025-06-30	TRDAEntrada Therapeutics, Inc.S Sale	Director	SSale	−18.6K sh	$6.81	−$127K	3,201,709
2025-06-27	TRDAEntrada Therapeutics, Inc.S Sale	Director	SSale	−55.7K sh	$6.91	−$385K	3,220,287
2025-06-27	TRDAEntrada Therapeutics, Inc.S Sale	Director	SSale	−19.3K sh	$6.91	−$133K	1,113,092
2025-06-11	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19K sh	—	—	19,000
2024-06-13	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2024-05-15	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+16.5K sh	—	—	16,500
2024-01-02	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+27.1K sh	$1.77	+$48K	27,118
2023-06-08	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2023-05-17	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+15.5K sh	—	—	15,490
2023-03-07	RLYBRallybio CorpS Sale	Director	SSale	−100K sh	$8.20	−$820K	2,378,969
2023-01-03	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+10.3K sh	—	—	10,344
2022-12-01	Akouos, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−16K sh	—	—	0
2022-11-30	Akouos, Inc.U Disposition from Tender	Director, 10% Owner	UDisposition from Tender	−982K sh	—	—	0
2022-11-30	Akouos, Inc.U Disposition from Tender	Director, 10% Owner	UDisposition from Tender	−3.15M sh	—	—	0
2022-06-23	Akouos, Inc.Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+16K sh	—	—	16,000
2022-06-15	QTTBQ32 Bio Inc. · Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2022-06-14	VORVor Biopharma Inc. · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+16.9K sh	—	—	16,911
2022-06-03	RLYBRallybio CorpS Sale	Director	SSale	−99.7K sh	$12.50	−$1.25M	2,478,969
2022-06-03	RLYBRallybio CorpS Sale	Director	SSale	−50.3K sh	$12.50	−$629K	1,251,755
2022-06-02	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.9K sh	—	—	11,918
2022-05-24	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+13.4K sh	—	—	13,440
2022-05-23	RLYBRallybio CorpS Sale	Director	SSale	−33.6K sh	$13.00	−$436K	1,302,084
2022-05-23	RLYBRallybio CorpS Sale	Director	SSale	−66.4K sh	$13.00	−$864K	2,578,640
2022-02-08	RLYBRallybio CorpS Sale	Director	SSale	−70.5K sh	$13.05	−$920K	1,335,637
2022-02-08	RLYBRallybio CorpS Sale	Director	SSale	−140K sh	$13.05	−$1.82M	2,645,087
2022-01-03	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+5,772 sh	—	—	5,772
2021-11-16	VORVor Biopharma Inc.S Sale	Director, 10% Owner	SSale	−91.8K sh	$15.30	−$1.41M	1,766,634
2021-11-16	VORVor Biopharma Inc.S Sale	Director, 10% Owner	SSale	−239K sh	$15.30	−$3.65M	4,595,089
2021-11-02	TRDAEntrada Therapeutics, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−318K sh	—	—	0
2021-11-02	TRDAEntrada Therapeutics, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−564K sh	—	—	0
2021-11-02	TRDAEntrada Therapeutics, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−255K sh	—	—	0
2021-11-02	TRDAEntrada Therapeutics, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−2.37M sh	—	—	0
2021-11-02	TRDAEntrada Therapeutics, Inc. · Series Seed Preferred StockC Conversion	Director	CConversion	−319K sh	—	—	0
2021-11-02	TRDAEntrada Therapeutics, Inc.P Purchase	Director	PPurchase	+250K sh	$20.00	+$5M	1,132,357
2021-11-02	TRDAEntrada Therapeutics, Inc.C Conversion	Director	CConversion	+318K sh	—	—	882,357
2021-11-02	TRDAEntrada Therapeutics, Inc.C Conversion	Director	CConversion	+255K sh	—	—	3,276,022
2021-11-02	TRDAEntrada Therapeutics, Inc.C Conversion	Director	CConversion	+564K sh	—	—	564,217
2021-11-02	TRDAEntrada Therapeutics, Inc.C Conversion	Director	CConversion	+2.37M sh	—	—	3,021,510

Recent filings

Accepted (ET)
Aug 104
PARMAR KUSH0001664281-26-000004
SEC(opens sec.gov)
Aug 34
PARMAR KUSH0001664281-26-000002
SEC(opens sec.gov)
Jun 124
PARMAR KUSH0001689375-26-000047
SEC(opens sec.gov)
Nov 184
PARMAR KUSH0001664281-25-000003
SEC(opens sec.gov)
Jul 114
PARMAR KUSH0001415889-25-019680
SEC(opens sec.gov)
Jul 14
PARMAR KUSH0001415889-25-018824
SEC(opens sec.gov)
Jun 124
PARMAR KUSH0001689375-25-000034
SEC(opens sec.gov)
Jun 144
PARMAR KUSH0001689375-24-000038
SEC(opens sec.gov)
May 174
PARMAR KUSH0001739410-24-000091
SEC(opens sec.gov)
Jan 44
PARMAR KUSH0001739410-24-000004
SEC(opens sec.gov)
Jun 124
PARMAR KUSH0001104659-23-070338
SEC(opens sec.gov)

Companies

Address

4 EMBARCADERO CENTER, SUITE 3110

SAN FRANCISCO, CA, 94111